Zurich, Switzerland
REGEDENT AG is a Swiss-based startup founded in 2014, specializing in innovative biomaterials aimed at accelerating hard and soft tissue regeneration in the fields of periodontal and peri-implant reconstruction, as well as guided bone regeneration. Its slogan, "Preserve Teeth & Implants with Novel Regenerative Concepts," succinctly captures its core mission.
The company's product portfolio includes Hyadent BG (hyaluronic acid), Perisolv (amino acids, hypochlorite), Smartbrane (porcine pericard membrane), and Smartgraft (bone xenografts), all of which are tailored to meet the specific needs of professionals in the regenerative and implant dentistry field.
REGEDENT AG has leveraged its management team's extensive experience to provide high-quality, customized products and solutions, enabling dental professionals to enhance their patients' health and quality of life. Moreover, the company actively engages with its target audience through its Facebook group, "Hyaluronic acid in dental surgery," fostering a community around its core product offering.
The startup operates within the Health Care, Manufacturing, and Medical Devices industries, emphasizing its commitment to addressing critical healthcare needs through innovative solutions.
Although specific details regarding the latest investment, investors, and headquarters are not provided, REGEDENT AG's focus on pioneering regenerative concepts in dental care presents an intriguing opportunity for potential investors seeking innovative ventures within the healthcare and medical device sectors.
-logo.jpg "MBCP® Technology (Advanced Medical Solutions)"){kind=logo}
